University of Leicester
Browse
1/1
2 files

Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies

journal contribution
posted on 2008-04-28, 10:11 authored by Melanie J. Davies, Patrick Sinnassamy, Fred Storms, Ramon Gomis
The AT.LANTUS trial recently demonstrated the efficacy and safety of insulin glargine initiation and maintenance using two different treatment algorithms in poorly controlled type 2 diabetes mellitus (T2DM). This sub-analysis investigated glycemic control and safety in 686 patients switching from premixed insulin (premix) with or without (±OADs) to once-daily glargine (±OADs/prandial insulin). A 24-week, multinational (n = 59), multicenter (n = 611), randomized study comparing two algorithms (Algorithm 1: clinic-driven titration; Algorithm 2: patient-driven titration) in four glargine ± OADs treatment groups: alone, once- (OD), twice- (BD) or >twice- (>BD) daily prandial insulin. After switching to the glargine regimen, HbA1c levels significantly improved in the overall group (9.0 ± 1.3 to 8.0 ± 1.2%; p < 0.001) and in all subgroups; fasting blood glucose levels also improved in all subgroups (overall: 167.1 ± 50.0 to 106.9 ± 27.2 mg/dL [9.3 ± 2.8 to 5.9 ± 1.5 mmol/L]; p < 0.001). The incidence of severe hypoglycemia was also low in all four subgroups (≤1.7%). Patients with T2DM switching from premix ± OADs to glargine ± OADs had significant reductions in glycemic control with a low incidence of severe hypoglycemia. The addition of prandial (OD, BD or >BD) insulin was associated with further improvements in glycemic control. These data provide support for the stepwise introduction of prandial insulin to a more physiologic basal–bolus regimen, which is under investigation.

History

Citation

Diabetes Research and Clinical Practice, 79 (2), pp.368-375

Published in

Diabetes Research and Clinical Practice

Publisher

Elsevier

Available date

2008-04-28

Publisher version

http://www.sciencedirect.com/science/article/pii/S0168822707004986

Notes

This is the author's final draft of the version published as Diabetes Research and Clinical Practice, 79 (2), pp.368-375. The online version can be accessed via http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T5Y-4R2GRT2-2&_user=123215&_coverDate=02/29/2008&_rdoc=30&_fmt=high&_orig=browse&_srch=doc-info(#toc#5015#2008#999209997#679136#FLA#display#Volume)&_cdi=5015&_sort=d&_docanchor=&_ct=38&_acct=C000010181&_version=1&_urlVersion=0&_userid=123215&md5=67a0c4a953dbe91a04a0172e6af36d1b

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC